EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PTRH2 Gene Variants: Recent Review of the Phenotypic Features and Their Bioinformatics Analysis

Rajech Sharkia iD, Sahil Jain, Muhammad Mahajnah, Clair Habib, Abdussalam Azem, Wasif Al-Shareef, Abdelnaser Zalan iD

Genes · 2023

DOI: 10.3390/genes14051031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2023. Verfasst von Rajech Sharkia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Human Biology and Genetics, Triangle Regional Research and Development Center, Kfar Qari 30075, Israel. Hauptthemen laut MEDLINE: Nervous System Malformations, Cerebellar Ataxia, Mitochondrial Proteins, Carboxylic Ester Hydrolases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Triangle Research and Development Center (TRDC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peptidyl-tRNA hydrolase 2 (PTRH2) is an evolutionarily highly conserved mitochondrial protein. The biallelic mutations in the PTRH2 gene have been suggested to cause a rare autosomal recessive disorder characterized by an infantile-onset multisystem neurologic endocrine and pancreatic disease (IMNEPD). Patients with IMNEPD present varying clinical manifestations, including global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, sensorineural hearing loss, and abnormalities of thyroid, pancreas, and liver. In the current study, we conducted an extensive literature review with an emphasis on the variable clinical spectrum and genotypes in patients. Additionally, we reported on a new case with a previously documented mutation. A bioinformatics analysis of the various PTRH2 gene variants was also carried out from a structural perspective. It appears that the most common clinical characteristics among all patients include motor delay (92%), neuropathy (90%), distal weakness (86.4%), intellectual disability (84%), hearing impairment (80%), ataxia (79%), and deformity of head and face (~70%). The less common characteristics include hand deformity (64%), cerebellar atrophy/hypoplasia (47%), and pancreatic abnormality (35%), while the least common appear to be diabetes mellitus (~30%), liver abnormality (~22%), and hypothyroidism (16%). Three missense mutations were revealed in the PTRH2 gene, the most common one being Q85P, which was shared by four different Arab communities and was presented in our new case. Moreover, four different nonsense mutations in the PTRH2 gene were detected. It may be concluded that disease severity depends on the PTRH2 gene variant, as most of the clinical features are manifested by nonsense mutations, while only the common features are presented by missense mutations. A bioinformatics analysis of the various PTRH2 gene variants also suggested the mutations to be deleterious, as they seem to disrupt the structural confirmation of the enzyme, leading to loss of stability and functionality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nervous System MalformationsCerebellar AtaxiaMitochondrial ProteinsCarboxylic Ester HydrolasesDevelopmental DisabilitiesMutationHumansCerebellumCodon, NonsenseAtaxia

Stichwörter der Autor:innen

IMNEPDPTRH2 genePTRH2 variantsautosomal recessive disorderbioinformatics analysisclinical featuresrare genetic diseases

Substanzen

Codon, NonsensePTH2 protein, humanCarboxylic Ester HydrolasesMitochondrial Proteins

Autor:innen und Institutionen

  • Unit of Human Biology and Genetics, Triangle Regional Research and Development Center, Kfar Qari 30075, Israel.
  • Unit of Natural Sciences, Beit-Berl Academic College, Beit-Berl 4490500, Israel.
  • Department of Biochemistry and Molecular Biology, Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.
  • The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel.
  • Child Neurology and Development Center, Hillel Yaffe Medical Center, Hadera 38100, Israel.
  • Genetics Institute, Rambam Health Care Campus, Haifa 31096, Israel.

ORCID-Profile: Rajech Sharkia, Abdelnaser Zalan

Förderung

  • Triangle Research and Development Center (TRDC)

Zitieren

APA

Sharkia, R., Jain, S., Mahajnah, M., Habib, C., Azem, A., Al-Shareef, W., & Zalan, A. (2023). PTRH2 Gene Variants: Recent Review of the Phenotypic Features and Their Bioinformatics Analysis. Genes. https://doi.org/10.3390/genes14051031

Vancouver

Sharkia R, Jain S, Mahajnah M, Habib C, Azem A, Al-Shareef W, et al. PTRH2 Gene Variants: Recent Review of the Phenotypic Features and Their Bioinformatics Analysis. Genes. 2023. doi:10.3390/genes14051031

BibTeX
@article{Sharkia2023,
  author = {Sharkia, Rajech and Jain, Sahil and Mahajnah, Muhammad and Habib, Clair and Azem, Abdussalam and Al-Shareef, Wasif and Zalan, Abdelnaser},
  title = {PTRH2 Gene Variants: Recent Review of the Phenotypic Features and Their Bioinformatics Analysis},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14051031}
}
Kostenlos starten →